136 related articles for article (PubMed ID: 16597547)
1. Gene expression analysis of troglitazone reveals its impact on multiple pathways in cell culture: a case for in vitro platforms combined with gene expression analysis for early (idiosyncratic) toxicity screening.
Vansant G; Pezzoli P; Saiz R; Birch A; Duffy C; Ferre F; Monforte J
Int J Toxicol; 2006; 25(2):85-94. PubMed ID: 16597547
[TBL] [Abstract][Full Text] [Related]
2. Species-specific toxicity of diclofenac and troglitazone in primary human and rat hepatocytes.
Lauer B; Tuschl G; Kling M; Mueller SO
Chem Biol Interact; 2009 Apr; 179(1):17-24. PubMed ID: 19022234
[TBL] [Abstract][Full Text] [Related]
3. Differences in hepatotoxicity and gene expression profiles by anti-diabetic PPAR gamma agonists on rat primary hepatocytes and human HepG2 cells.
Guo L; Zhang L; Sun Y; Muskhelishvili L; Blann E; Dial S; Shi L; Schroth G; Dragan YP
Mol Divers; 2006 Aug; 10(3):349-60. PubMed ID: 17031537
[TBL] [Abstract][Full Text] [Related]
4. Increased sensitivity for troglitazone-induced cytotoxicity using a human in vitro co-culture model.
Edling Y; Sivertsson LK; Butura A; Ingelman-Sundberg M; Ek M
Toxicol In Vitro; 2009 Oct; 23(7):1387-95. PubMed ID: 19631733
[TBL] [Abstract][Full Text] [Related]
5. Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in rat hepatocytes.
Rogue A; Renaud MP; Claude N; Guillouzo A; Spire C
Toxicol Appl Pharmacol; 2011 Jul; 254(1):18-31. PubMed ID: 21515302
[TBL] [Abstract][Full Text] [Related]
6. Species-specific toxicity of troglitazone on rats and human by gel entrapped hepatocytes.
Shen C; Meng Q; Zhang G
Toxicol Appl Pharmacol; 2012 Jan; 258(1):19-25. PubMed ID: 22085495
[TBL] [Abstract][Full Text] [Related]
7. Thiazolidinedione bioactivation: a comparison of the bioactivation potentials of troglitazone, rosiglitazone, and pioglitazone using stable isotope-labeled analogues and liquid chromatography tandem mass spectrometry.
Alvarez-Sanchez R; Montavon F; Hartung T; Pähler A
Chem Res Toxicol; 2006 Aug; 19(8):1106-16. PubMed ID: 16918252
[TBL] [Abstract][Full Text] [Related]
8. The mitochondrial superoxide/thioredoxin-2/Ask1 signaling pathway is critically involved in troglitazone-induced cell injury to human hepatocytes.
Lim PL; Liu J; Go ML; Boelsterli UA
Toxicol Sci; 2008 Feb; 101(2):341-9. PubMed ID: 17975114
[TBL] [Abstract][Full Text] [Related]
9. Direct toxicity effects of sulfo-conjugated troglitazone on human hepatocytes.
Saha S; New LS; Ho HK; Chui WK; Chan EC
Toxicol Lett; 2010 Jun; 195(2-3):135-41. PubMed ID: 20307632
[TBL] [Abstract][Full Text] [Related]
10. Carcinogenic susceptibility of rasH2 mice to troglitazone.
Jin M; Takahashi M; Moto M; Muguruma M; Ito K; Watanabe K; Kenmochi Y; Kono T; Hasumi K; Mitsumori K
Arch Toxicol; 2007 Dec; 81(12):883-94. PubMed ID: 17569031
[TBL] [Abstract][Full Text] [Related]
11. Troglitazone inhibits synthesis of transforming growth factor-beta1 and reduces matrix production in human peritoneal mesothelial cells.
Peng Y; Liu H; Liu F; Liu Y; Li J; Chen X
Nephrology (Carlton); 2006 Dec; 11(6):516-23. PubMed ID: 17199790
[TBL] [Abstract][Full Text] [Related]
12. Gene expression regulated by pioglitazone and exenatide in normal and diabetic rat islets exposed to lipotoxicity.
Ghanaat-Pour H; Sjöholm A
Diabetes Metab Res Rev; 2009 Feb; 25(2):163-84. PubMed ID: 19065603
[TBL] [Abstract][Full Text] [Related]
13. Keratinocyte-derived vascular endothelial growth factor biosynthesis represents a pleiotropic side effect of peroxisome proliferator-activated receptor-gamma agonist troglitazone but not rosiglitazone and involves activation of p38 mitogen-activated protein kinase: implications for diabetes-impaired skin repair.
Schiefelbein D; Seitz O; Goren I; Dissmann JP; Schmidt H; Bachmann M; Sader R; Geisslinger G; Pfeilschifter J; Frank S
Mol Pharmacol; 2008 Oct; 74(4):952-63. PubMed ID: 18599600
[TBL] [Abstract][Full Text] [Related]
14. A novel selective peroxisome proliferator-activator receptor-gamma modulator-SPPARgammaM5 improves insulin sensitivity with diminished adverse cardiovascular effects.
Chang CH; McNamara LA; Wu MS; Muise ES; Tan Y; Wood HB; Meinke PT; Thompson JR; Doebber TW; Berger JP; McCann ME
Eur J Pharmacol; 2008 Apr; 584(1):192-201. PubMed ID: 18346728
[TBL] [Abstract][Full Text] [Related]
15. Effect of troglitazone on CYP1A1 induction.
Kim HG; Han EH; Jeong HG
Toxicology; 2008 Apr; 246(2-3):166-71. PubMed ID: 18308446
[TBL] [Abstract][Full Text] [Related]
16. Rosiglitazone increases PPARgamma in renal tubular epithelial cells and protects against damage by hydrogen peroxide.
Sommer M; Wolf G
Am J Nephrol; 2007; 27(4):425-34. PubMed ID: 17622750
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of direct and indirect effects of the PPARγ agonist troglitazone on mouse endothelial cell proliferation.
Kakiuchi-Kiyota S; Arnold LL; Yokohira M; Koza-Taylor P; Suzuki S; Varney M; Pennington KL; Cohen SM
Toxicol Pathol; 2011 Dec; 39(7):1032-45. PubMed ID: 21937740
[TBL] [Abstract][Full Text] [Related]
18. Investigation of the role of the thiazolidinedione ring of troglitazone in inducing hepatotoxicity.
Saha S; New LS; Ho HK; Chui WK; Chan EC
Toxicol Lett; 2010 Feb; 192(2):141-9. PubMed ID: 19854250
[TBL] [Abstract][Full Text] [Related]
19. Pyrrolidinediones reduce the toxicity of thiazolidinediones and modify their anti-diabetic and anti-cancer properties.
Saha S; Chan DS; Lee CY; Wong W; New LS; Chui WK; Yap CW; Chan EC; Ho HK
Eur J Pharmacol; 2012 Dec; 697(1-3):13-23. PubMed ID: 23041271
[TBL] [Abstract][Full Text] [Related]
20. Troglitazone induces cytotoxicity in part by promoting the degradation of peroxisome proliferator-activated receptor γ co-activator-1α protein.
Liao X; Wang Y; Wong CW
Br J Pharmacol; 2010 Oct; 161(4):771-81. PubMed ID: 20860658
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]